HOOKIPA Pharma
HOOK
HOOK was delisted on the 7th of August, 2025.
71 hedge funds and large institutions have $114M invested in HOOKIPA Pharma in 2021 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 25 increasing their positions, 13 reducing their positions, and 11 closing their positions.
92% more repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 13
82% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 11
15% more funds holding
Funds holding: 62 → 71 (+9)
0.34% more ownership
Funds ownership: 4.47% → 4.81% (+0.34%)
27% less capital invested
Capital invested by funds: $156M → $114M (-$41.6M)
85% less call options, than puts
Call options by funds: $326K | Put options by funds: $2.18M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$5.17M |
| 2 |
UBS AM
Chicago,
Illinois
|
+$4.42M |
| 3 |
BlackRock
New York
|
+$4.09M |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
+$2.95M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$2.91M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$6.97M |
| 2 |
HA
HHLR Advisors
Grand Cayman,
Cayman Islands
|
-$6.22M |
| 3 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$5.17M |
| 4 |
Goldman Sachs
New York
|
-$1.86M |
| 5 |
MS
Maven Securities
St Helier,
Jersey
|
-$661K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
76
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| – | -$152K | -1,126 | Closed |
|
|
RJA
77
Raymond James & Associates
St Petersburg,
Florida
| – | -$142K | -1,059 | Closed |
|
78
Bank of Montreal
Toronto,
Ontario, Canada
| – | -$7K | -50 | Closed |
|
|
SPIA
79
Steward Partners Investment Advisory
New York
| – | -$4.71K | -35 | Closed |
|
|
RCA
80
Ranch Capital Advisors
Sarasota,
Florida
| – | -$1K | -10 | Closed |
|
|
SBL
81
Sargent Bickham Lagudis
Boulder,
Colorado
| – | -$1K | -10 | Closed |
|
HOOK Hedge Fund Activity: Q2 2021 in Review
71 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in HOOKIPA Pharma (HOOK) for Q2 2021, worth a combined $114M — down 27% from $156M a quarter earlier.
Buyers outnumbered sellers: 20 funds opened new HOOK positions and 11 closed out — a net gain of 9 holders — while 25 added to existing stakes and 13 trimmed.
The largest buyer was Millennium Management, opening a new position worth an estimated $5.17M. The largest seller was Fidelity Investments, cutting an estimated $6.97M.
- 71 institutional investors held HOOKIPA Pharma (HOOK) as of Q2 2021, up from 62 in Q1 2021.
- Funds reported $114M of HOOKIPA Pharma stock for Q2 2021, down 27% quarter-over-quarter.
- 20 funds opened new HOOKIPA Pharma positions in Q2 2021 and 11 closed out, a net change of +9 holders.
- The largest HOOKIPA Pharma buyer in Q2 2021 was Millennium Management, an estimated $5.17M added.
- The largest HOOKIPA Pharma seller in Q2 2021 was Fidelity Investments, an estimated $6.97M sold.
Based on aggregated 13F filings for Q2 2021.